First Trust Direct Indexing’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,467
Closed -$1.28M 307
2024
Q3
$1.28M Sell
19,467
-2,289
-11% -$166K 0.07% 286
2024
Q2
$2.01M Buy
21,756
+2,517
+13% +$223K 0.12% 162
2024
Q1
$1.84M Buy
19,239
+1,804
+10% +$152K 0.14% 155
2023
Q4
$1.33M Buy
17,435
+932
+6% +$64.8K 0.12% 190
2023
Q3
$1.14M Sell
16,503
-61
-0.4% -$4.9K 0.13% 175
2023
Q2
$1.56M Buy
16,564
+1,995
+14% +$173K 0.17% 131
2023
Q1
$1.21M Buy
14,569
+175
+1% +$13.8K 0.14% 168
2022
Q4
$1.07M Sell
14,394
-1,424
-9% -$110K 0.14% 181
2022
Q3
$1.31M Buy
15,818
+186
+1% +$17.9K 0.19% 129
2022
Q2
$1.49M Buy
15,632
+743
+5% +$76.9K 0.21% 116
2022
Q1
$1.75M Buy
14,889
+2,679
+22% +$301K 0.21% 97
2021
Q4
$1.58M Buy
12,210
+519
+4% +$60.5K 0.21% 107
2021
Q3
$1.32M Buy
11,691
+116
+1% +$13.2K 0.19% 119
2021
Q2
$1.2M Buy
11,575
+2,825
+32% +$266K 0.18% 142
2021
Q1
$732K Buy
8,750
+398
+5% +$33.6K 0.2% 146
2020
Q4
$762K Buy
+8,352
New +$693K 0.21% 120

Other funds holding EW

First Trust Direct Indexing's EW Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 19,467 shares — an estimated $1.28M sold.

First Trust Direct Indexing first reported a position in EW in Q4 2020 and held it in 16 quarters. The position peaked at $2.01M in Q2 2024. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 19,467 Edwards Lifesciences shares in Q4 2024, an estimated $1.28M.
  • First Trust Direct Indexing first reported a position in Edwards Lifesciences in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Edwards Lifesciences position peaked at $2.01M in Q2 2024.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.